Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2018-12-01
2019-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Deficit in Women With Uterine Fibroids
NCT04030182
Correlation Between Serum Vitamin D3 and Incidence of Uterine Leiomyoma
NCT05151393
Effect of Vitamin D on the Size of Fibroids in Women With Vitamin D Deficiency
NCT03991078
Association Between Vitamin D and the Development of Uterine Fibroids
NCT03584529
Association Between Vitamin D and the Risk of Uterine Fibroids
NCT03586947
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
In Woman With Myoma Uteri
No interventions assigned to this group
control group
In Woman Without Myoma Uteri
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* chronic systemic disease
* malignancy
* history of adenomyosis
* women in menopause
* pregnant women
* vitamin D supplementation
* lactation
* abortion and pregnancy loss in the last 6 months
* oral contraceptive / hormonal agents in the last 3 months
25 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Kadirogulları
pınar kadiroğulları M.D, Department of Obstetrics and Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018/11/43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.